Apeloa Pharmaceutical Co.,Ltd
000739
Ранг среди акций
#4312
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Цена акции
$3.17
Рыночная капитализация
$3.67B
Изменение (1 день)
0.76%
Изменение (1 год)
40.57%
Страна
CN
Торговля Apeloa Pharmaceutical Co.,Ltd (000739)
Категория
Healthcare
EPS для Apeloa Pharmaceutical Co.,Ltd (000739)
EPS по состоянию на June 2026 TTM: $0.11
Согласно последним финансовым отчетам и цене акций Apeloa Pharmaceutical Co.,Ltd, текущий EPS компании (TTM) составляет $0.11. В конце 2023 EPS компании составлял $0.13, больше, чем показателю 2022 года, равному $0.12.
История EPS компании Apeloa Pharmaceutical Co.,Ltd с 2000 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2024 | $0.12 | -4.09% |
| 2023 | $0.13 | 3.17% |
| 2022 | $0.12 | -3.30% |
| 2021 | $0.13 | 20.64% |
| 2020 | $0.11 | 56.44% |
| 2019 | $0.07 | 47.70% |
| 2018 | $0.05 | 35.21% |
| 2017 | $0.03 | 2.11% |
| 2016 | $0.03 | 19.49% |
| 2015 | $0.03 | -42.77% |
| 2014 | $0.05 | 39.88% |
| 2013 | $0.03 | -22.94% |
| 2012 | $0.04 | 265.04% |
| 2011 | $0.01 | 136.54% |
| 2010 | $0.01 | -30.67% |
| 2009 | $0.01 | 17.19% |
| 2008 | $0.01 | -3.03% |
| 2007 | $0.01 | -45.00% |
| 2006 | $0.01 | 57.89% |
| 2005 | $0.01 | 24.59% |
| 2004 | $0.01 | 5.17% |
| 2003 | $0.01 | 7.41% |
| 2002 | $0.01 | -210.20% |
| 2001 | 0.00 | 716.67% |
| 2000 | 0.00 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
